View Press Releases
-
CloudLIMS Announces Collaboration with Folio for Secure Issuance of COVID-19 Results to Patients
CloudLIMS’ COVID-19 LIMS solution has integrated with Folio's mobile app to enable receiving, storing, and sharing of COVID-19 test results securely and digitally.
Feb 15, 2021
-
NSTDA-BIOTEC selects Key Organics BIONET Fragment Library to identify new non-pyrimidine inhibitors of malaria parasite Plasmodium falciparum dihydrofolate reductase (PfDHFR).
In recent research at BIOTEC1 a three-step fragment-based screening of PfDHFR was undertaken employing Key Organics BIONET Premium library containing 1163 fragments. This library was chosen over other commercial ones as it is rule-of-three compliant and was curated from any PAINS and aggregating compounds. All fragments are also soluble at 200 mM in DMSO and display high diversity.
Feb 15, 2021
-
ComputaBio is Capable to provide Drug Design Services
ComputaBio, a US supplier of computational biology services, claims to be a capable helping hand in drug design for industrial and academic scientists worldwide to expedite their drug development projects.
Feb 23, 2021
-
VisualDx Launches Project IMPACT to Address Racism and Implicit Bias in Medicine
-
IntelyCare Hires David Burke as CFO to Drive Business Growth and Momentum; Address Intensifying Staffing Demands in Post-Acute Space
IntelyCare hires David Burke as chief financial officer to support the continued success and expansion of the company.
Feb 23, 2021
-
Alfa Chemistry: T,C&A Lab Unveils Ingredient Analysis Service
-
Creative Biostructure Performs Comprehensive Lead Discovery and Optimization Solutions
-
BOC Sciences Strengthens the Cooperation with Global Biotechnology Companies to Promote ADCs Development & Research
-
KCR opens new branch in Sydney, Australia
KCR, the international clinical development solutions provider, today announced the establishment of a new branch in Sydney, Australia. The new location will enhance KCR’s regional coverage and maximize clinical capabilities for clients across the globe.
Feb 24, 2021
-
KROHNE Features OPTIMASS 1000 Straight Tube Coriolis Mass Meter
KROHNE, Inc. features its OPTIMASS 1000 Straight Tube Coriolis Mass Meter manufactured at its state of the art flow and level instrument manufacturing and calibration facility located in Beverly, MA. OPTIMASS 1000 is designed for exceptional measurement capabilities with the flexibility and options of high-end meters, at a competitive price. The OPTIMASS 1000 is well-suited for a variety of industries, including the chemical, petrochemical, food and beverage, water and pharmaceutical, and can operate reliably between -40 and 130° C.
Feb 24, 2021
-
Pfannenberg Datawind Filterfans® Cool in IT Environments without Sacrificing Valuable Rack Space
Purpose-built product is ideal for space-restricted and manufacturing floor IT installations
Feb 21, 2021
-
Rousselot Biomedical joins European ENLIGHT project to develop a 3D living model of pancreatic tissue
In the European project ENLIGHT, researchers from academic centers and leading industries across Europe are joining forces to develop a living model of the pancreas to enable better testing of diabetes medication.
Feb 21, 2021
-
CellPort Software Announces Release of CellPort Cell Culture Suite
CellPort Software today announced the launch of the CellPort Cell Culture Suite, a new cloud-based Software as a Service (SaaS) product focused on cell culture and cell banking. CellPort Cell Culture Suite is a secure, compliant SaaS-based application suite focused on managing all lab workflows, activities, equipment, materials, personnel, data/calculations, locations, and projects for cell culture and cell banking. CellPort reduces errors, increases reproducibility, enhances productivity, and provides full audit-ready traceability for regulated and unregulated environments.
Feb 15, 2021
-
Study Shows Biocept’s Target Selector™ Detects Mutations in “Quantity Not Sufficient” Specimens in Non-Small Cell Lung Cancer Patients
Biocept presents data showing its Target Selector molecular assay kit detects mutations in up to 50% of tissue biopsy specimens, from patients diagnosed with non-small cell lung cancer, that were deemed quantity not sufficient (QNS).
Feb 15, 2021
-
MedAI Releases Drug Formulation Development Service for the Pharmaceutical Industry
-
Healthtech company Raremark® reboots as XperiomeTM to drive increased value for rare disease patients and researchers
-
PHARMASEAL’s Engility® platform fights off competition to be selected by award-winning US Medical Device company
-
Whole Genome Sequencing for GutFlora Now Available by the GutFlora Omics Platform
The product manager of Creative Proteomics has recently announced the fully-developed whole-genome sequencing, which can work as a powerful tool in multiple areas including diagnosis, tracking disease outbreaks, characterizing causative mutations and identifying drug-resistance genes.
Feb 22, 2021
-
Solentim expands global reach, opening new operation in China
Solentim, the trusted global leader in cell therapy workflows enabling the creation, isolation and characterization of high value cells, announces the opening of a new office in Shanghai. Solentim China is a joint venture with its longstanding distribution partner Trio Biotech Co, and will enhance support for customers and expand commercial activity across the region.
Feb 22, 2021
-
Optibrium appoints Dr Rae Lawrence as Director of Software Development
New role will drive development of AI-based drug discovery software solutions and lead development team expansion
Feb 22, 2021